Cargando…
2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI
BACKGROUND: In the outpatient setting, IDSA guidelines recommend a 3-day course of highly bioavailable oral antibiotics (abx) for treatment of uncomplicated urinary tract infections(uUTI); however, hospitalized patients often receive IV abx and longer durations. Ceftriaxone (CRO) is well tolerated a...
Autores principales: | Elajouz, Balsam, Dumkow, Lisa E, VanLangen, Kali, Worden, Lacy, Jameson, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752508/ http://dx.doi.org/10.1093/ofid/ofac492.1841 |
Ejemplares similares
-
Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection
por: Elajouz, Balsam, et al.
Publicado: (2022) -
Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections
por: Worden, Lacy J, et al.
Publicado: (2021) -
189. Outcomes of High-dose Oral Beta-lactam Step-down Therapy Compared to Alternative Oral Therapy for Bacteremic Urinary Tract Infections
por: Geyer, Abigail, et al.
Publicado: (2023) -
Outcomes of high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection
por: Geyer, Abigail C., et al.
Publicado: (2023) -
695. Antipseudomonal Versus Narrow-spectrum Agents for the Treatment of Community-onset Intra-abdominal Infections
por: Worden, Lacy, et al.
Publicado: (2021)